ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-1,831 Cr | ₹-1,198 Cr | ₹-1,068 Cr | ₹-942 Cr | ₹-955 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ZYDUS LIFESCIENCES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-1,831 Cr |
| Mar2024 | ₹-1,198 Cr |
| Mar2023 | ₹-1,068 Cr |
| Mar2022 | ₹-942 Cr |
| Mar2021 | ₹-955 Cr |
How is Deferred Tax Assets / Liabilities of ZYDUS LIFESCIENCES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1,831 Cr | Negative | |
| Mar2024 | ₹-1,198 Cr | Negative | |
| Mar2023 | ₹-1,068 Cr | Negative | |
| Mar2022 | ₹-942 Cr | Negative | |
| Mar2021 | ₹-955 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ZYDUS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZYDUS LIFESCIENCES | ₹89,571.9 Cr | 2.3% | -1.6% | -8.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹381,326.0 Cr | -0.2% | -6.3% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,299.0 Cr | 3.3% | -3.4% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,821.0 Cr | -0.7% | 3.8% | 26.3% | Stock Analytics | |
| CIPLA | ₹106,655.0 Cr | -3% | -11.8% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,861.0 Cr | 6% | -3.5% | -4.3% | Stock Analytics | |
ZYDUS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZYDUS LIFESCIENCES | 2.3% |
-1.6% |
-8.7% |
| SENSEX | 0.8% |
-2.9% |
8.1% |
You may also like the below Video Courses